Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the field of biopharmaceuticals, offering promising developments throughout a variety of medical and industrial purposes. With its structural similarity to Obviously derived human serum albumin, OsrHSA supplies a safer, more dependable alternative for therapeutic us